You have 9 free searches left this month | for more free features.

chronic myeloid leukaemia

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Outcomes in Chronic Myeloid Leukaemia

Completed
  • Chronic Myeloid Leukaemia
    • York, United Kingdom
      Haematological Malignancy Research Network
    Jun 7, 2023

    Landscape and Real-life Treatment Outcomes in Hungary: Analysis

    Completed
    • Chronic Myeloid Leukaemia
    • Budapest, Hungary
      Pfizer
    Dec 15, 2022

    Chronic Myeloid Leukemia in Myeloid Blast Crisis, Chronic Myeloid Leukaemia Transformation, Chronic Myeloid Leukemia -

    Recruiting
    • Chronic Myeloid Leukemia in Myeloid Blast Crisis
    • +3 more
    • based decitabine and olverembatinib(HQP1351)chemotherapy
    • Guanzhou, China
      Department of Hematology, Nanfang Hospital, Southern Medical Uni
    Dec 6, 2022

    Condition Vasoregulation Function Endothelium in CML Getting TKI

    Recruiting
    • Chronic Myeloid Leukaemia
    • taking blood for the study of biochemical parameters and the study of microcirculation using the method of laser Doppler flowmetry
    • Moscow, Russian Federation
    • +1 more
    Jan 11, 2023

    Myeloid Leukemia, Chronic Trial in France (Glivec)

    Terminated
    • Myeloid Leukemia, Chronic
    • Bordeaux, France
    • +6 more
    Nov 5, 2021

    Chronic Myeloid Leukaemia Recurrent, Chronic Myeloid Leukemia, in Relapse Trial in Huixquilucan (Myeloid mutations measurement)

    Recruiting
    • Chronic Myeloid Leukaemia Recurrent
    • Chronic Myeloid Leukemia, in Relapse
    • Myeloid mutations measurement
    • Huixquilucan, Estado De México, Mexico
      Grupo Cooperativo de Hemopatías Malignas
    Oct 4, 2021

    MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Sydney (Decitabine/Cedazuridine 35 Mg-100 Mg ORAL TABLET,

    Recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • Decitabine/Cedazuridine 35 Mg-100 Mg ORAL TABLET
    • Defactinib
    • Sydney, New South Wales, Australia
    • +3 more
    Jan 12, 2023

    Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Acute Myeloid Leukaemia Trial in United Kingdom (Reduced intensity haplodentical

    Active, not recruiting
    • Hodgkin's Lymphoma
    • +8 more
    • Reduced intensity haplodentical stem cell transplant
    • Myeloablative haploidentical stem cell transplant
    • Birmingham, United Kingdom
    • +11 more
    Sep 27, 2021

    International Chronic Myeloid Leukemia Pediatric Study

    Recruiting
    • Chronic Myeloid Leukemia
      • Buenos Aires, Argentina
      • +20 more
      Mar 22, 2022

      Imatinib-resistant/Intolerant Chronic Myeloid Leukemia Treated

      Completed
      • Chronic Myeloid Leukaemia
      • Rionero in Vulture, Potenza, Italy
      • +32 more
      Oct 24, 2022

      Acute Myeloid Leukaemia; MDS;Chronic Myelomonocytic Leukemia Trial in Shenzhen (Azacytidine, HAG Regimen, Azacytidine)

      Recruiting
      • Acute Myeloid Leukaemia; Myelodysplastic Syndromes;Chronic Myelomonocytic Leukemia
      • Shenzhen, Guangdong, China
        Shenzhen Second People's Hospital
      Mar 14, 2022

      BCR-ABL+ Chronic Myeloid Leukaemia in Chronic Phase

      Active, not recruiting
      • Chronic Phase Philadelphia Positive
      • +2 more
        • Alessandria, Italy
        • +55 more
        Jan 4, 2022

        Acute Myeloid Leukemia, MDS Trial (idarubicin, Cytarabine)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • Myelodysplastic Syndromes
        • (no location specified)
        Sep 18, 2023

        Acute Myeloid Leukaemia Trial in Worldwide (S 64315 (also referred as MIK665) and azacitidine)

        Active, not recruiting
        • Acute Myeloid Leukaemia
        • S 64315 (also referred as MIK665) and azacitidine
        • Houston, Texas
        • +6 more
        Dec 16, 2022

        Acute Myeloid Leukaemia Trial in Australia, France, United States (S 64315 (also referred as MIK665) and venetoclax)

        Terminated
        • Acute Myeloid Leukaemia
        • S 64315 (also referred as MIK665) and venetoclax
        • New Haven, Connecticut
        • +6 more
        Dec 20, 2022

        Cancer, MDS-EB, MDS Trial in Athens, Southampton, Sheffield (INKmune)

        Recruiting
        • Cancer
        • +4 more
        • INKmune
        • Athens, Attiki, Greece
        • +2 more
        Jul 3, 2023

        Chronic Myeloid Leukemia (CML) Trial in France

        Recruiting
        • Chronic Myeloid Leukemia (CML)
          • Annecy, France
          • +11 more
          Jul 18, 2023

          Relapsed Acute Myeloid Leukaemia Trial (Cryopreserved BE CAR33 T Cells (BE752TBTTBCAR33PBL))

          Not yet recruiting
          • Relapsed Acute Myeloid Leukaemia
          • Cryopreserved BE CAR33 T Cells (BE752TBTTBCAR33PBL)
          • (no location specified)
          Jul 4, 2023

          Calquence CLL 1L Japan PMS _ Japan Post-Marketing Surveillance

          Not yet recruiting
          • Previously Untreated Chronic Lymphocytic Leukaemia (Including Small Lymphocytic Lymphoma)
            • (no location specified)
            Dec 16, 2022

            Acute Myeloid Leukemia in Remission Trial in Worldwide (DCP-001)

            Active, not recruiting
            • Acute Myeloid Leukemia in Remission
            • DCP-001
            • Helsinki, Finland
            • +9 more
            Oct 7, 2022

            Acute Myeloid Leukemia (AML) Trial in Nantes (Siltuximab)

            Not yet recruiting
            • Acute Myeloid Leukemia (AML)
            • Nantes, France
              CHU de Nantes
            Jan 24, 2023

            Acute Myeloid Leukemia Trial (TCB008)

            Recruiting
            • Acute Myeloid Leukemia
            • Bristol, United Kingdom
            • +5 more
            Jan 10, 2023

            Chronic Myeloid Leukemia Trial in New Zealand (Dasatinib, Imatinib)

            Recruiting
            • Chronic Myeloid Leukemia
            • Auckland, New Zealand
            • +8 more
            Mar 10, 2021

            Acalabrutinib in Chronic Lymphocytic Leukaemia in United Kingdom

            Recruiting
            • Chronic Lymphocytic Leukemia, CLL
            • Aylesbury, United Kingdom
            • +7 more
            Jan 12, 2023

            Chronic Myeloid Leukemia, Chronic Phase Trial in Monterrey (Dasatinib Pill, Ketoconazole Pill)

            Recruiting
            • Chronic Myeloid Leukemia, Chronic Phase
            • Dasatinib Pill
            • Ketoconazole Pill
            • Monterrey, Nuevo Leon, Mexico
              Hospital Universitario Dr. José Eleuterio González
            Nov 25, 2022